ClinicalTrials.Veeva

Menu

Real-time Decision Support for Postoperative Nausea and Vomiting (PONV) Prophylaxis

Vanderbilt University logo

Vanderbilt University

Status

Completed

Conditions

Postoperative Nausea and Vomiting

Treatments

Drug: Hydrocodone
Drug: Metoclopramide
Drug: Oxymorphone
Drug: Scopolamine
Drug: Droperidol
Procedure: Automated notification at the start of surgery
Drug: Hydromorphone
Procedure: Automated notification at the end of surgery
Drug: Alfentanil
Drug: Tropisetron
Procedure: Elective surgery
Drug: Propofol
Drug: Granisetron
Drug: Fentanyl
Drug: Remifentanil
Drug: Isoflurane
Drug: Haloperidol
Drug: Ramosetron
Drug: Aprepitant
Procedure: General anesthesia
Drug: Ketamine
Drug: Oxycodone
Device: Anesthesia Information Management System (AIMS)
Drug: Sevoflurane
Drug: Sufentanil
Drug: Meclizine
Drug: Promethazine
Drug: Methadone
Device: Perioperative Data Warehouse (PDW)
Drug: Desflurane
Drug: Morphine
Drug: Ondansetron
Drug: Dolasetron mesylate
Procedure: Automated recommendation at the start of the case
Drug: Meperidine
Drug: Palonosetron
Procedure: Preoperative recommendations: by email
Drug: Dexamethasone

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

The purpose of this study is to determine how automated recommendations are best presented to optimize the adherence to guidelines on prophylaxis for nausea and vomiting after surgery.

Full description

Nausea and vomiting after surgery (PONV) is a common side effect of the surgical procedure, general anesthesia and opioid use occurring in about one third of patients. In addition to being very unpleasant for patients, it is associated with longer recovery room stays and increased costs. Much research has been done on prophylactic interventions that may be applied during the surgical procedure to prevent PONV. Current national guidelines recommend that a risk score is used to decide on the number of prophylactic interventions to administer to a patient. Based on specific characteristics of individual patients and the procedures that they are about to undergo, such a risk score predicts the risk of PONV for each individual. According to the national guidelines, patients with higher risks of PONV should receive more prophylactic interventions. However, in a busy operating room where the anesthesia provider performs multiple patient care tasks, closely following the recommendations to minimize the risk of PONV is often difficult.

Computers may help anesthesia providers to adhere to best practices for PONV prevention by providing so-called decision support. A decision support system for PONV automatically calculates the risk of PONV for an individual patient and presents this predicted risk to the anesthesia provider on the computer screen that is being used by the anesthesia team for record keeping. In recent studies, such decision support systems have been demonstrated to improve adherence to PONV guidelines, especially when a recommendation on the number of interventions is added to the predicted risk. However, in these studies there was still quite some room for improvement of the adherence to PONV guidelines. In general, implementation science is only beginning to understand how such decision support systems are best used to improve medical decision making and minimize practice variations among providers. Further study of how the design of decision support systems impacts the decision making of healthcare providers is therefore warranted.

In this proposed study, the investigators will implement several decision support elements for PONV that aim to help anesthesia providers to adhere to the departmental PONV guidelines during the anesthetic case. The study consists of three phases. The first phase is the preintervention phase - i.e. before the decision support has been implemented. The second phase is the first intervention phase with one CDSS feature added. The third phase is the second intervention phase with another CDSS feature added.

The decision support elements will provide information about the patient's predicted risk of PONV and the number of prophylactic interventions that the departmental guidelines recommend based on that risk. We will start with preoperative email notifications, followed by an element within the anesthesia information management system (AIMS) that are displayed around the start and end of the procedure. All forms of decision support only provide recommendations. The anesthesia provider is free to act on the message or ignore the notifications.

The investigators will compare the adherence to PONV guidelines and the actual occurrence of PONV (both nausea and emetic events: vomiting and retching) in the post-anesthesia care unit (PACU) between all study phases and between the different interventions. The goal of the comparison is to evaluate which decision support elements have an added value to optimize guideline adherence for PONV prophylaxis.

Enrollment

27,034 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • All adult patients (18 years and older) that are scheduled for an elective surgical procedure under general anesthesia

Exclusion criteria

  • Patients undergoing emergency surgery or organ transplantation
  • Patients that are transferred directly to the Intensive Care Unit after the end of the procedure
  • Patients that die intraoperatively
  • Procedures that only require a sedative level of anesthesia

Trial design

Primary purpose

Prevention

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

27,034 participants in 1 patient group

PONV clinical decision support system
Experimental group
Description:
Automated recommendations on PONV prophylaxis provided to anesthesia providers through the anesthesia information management system and email.
Treatment:
Drug: Promethazine
Procedure: Automated recommendation at the start of the case
Drug: Ondansetron
Drug: Meperidine
Drug: Alfentanil
Drug: Palonosetron
Drug: Scopolamine
Device: Perioperative Data Warehouse (PDW)
Drug: Hydrocodone
Procedure: Automated notification at the start of surgery
Drug: Sufentanil
Drug: Ramosetron
Drug: Methadone
Drug: Isoflurane
Drug: Tropisetron
Drug: Hydromorphone
Drug: Droperidol
Procedure: Automated notification at the end of surgery
Procedure: Preoperative recommendations: by email
Procedure: General anesthesia
Procedure: Elective surgery
Drug: Dolasetron mesylate
Drug: Propofol
Drug: Fentanyl
Drug: Aprepitant
Drug: Haloperidol
Drug: Oxycodone
Drug: Desflurane
Drug: Sevoflurane
Drug: Metoclopramide
Device: Anesthesia Information Management System (AIMS)
Drug: Meclizine
Drug: Remifentanil
Drug: Oxymorphone
Drug: Ketamine
Drug: Dexamethasone
Drug: Granisetron
Drug: Morphine

Trial documents
1

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems